{"id":10545,"date":"2025-04-02T15:39:28","date_gmt":"2025-04-02T15:39:28","guid":{"rendered":"https:\/\/navarrahealthcluster.com\/arranca-nuestro-nuevo-ciclo-formativo-sobre-los-desafios-regulatorios-en-la-innovacion-farmaceutica-y-sanitaria\/"},"modified":"2025-05-07T15:53:31","modified_gmt":"2025-05-07T15:53:31","slug":"arranca-nuestro-nuevo-ciclo-formativo-sobre-los-desafios-regulatorios-en-la-innovacion-farmaceutica-y-sanitaria","status":"publish","type":"post","link":"https:\/\/navarrahealthcluster.com\/en\/arranca-nuestro-nuevo-ciclo-formativo-sobre-los-desafios-regulatorios-en-la-innovacion-farmaceutica-y-sanitaria\/","title":{"rendered":"Our new training series on regulatory challenges in pharmaceutical and healthcare innovation kicks off"},"content":{"rendered":"\n<p>Navarra Health Cluster and its member entity <a href=\"https:\/\/navarrahealthcluster.com\/en\/partners\/asphalion\/\">Asphalion <\/a>launched a new training cycle titled &#8220;Regulatory Challenges in Pharmaceutical and Healthcare Innovation&#8221; on Tuesday 1 April, with a first session focused on the regulatory hurdles involved in innovation for medical devices, covering procedures in both Europe and the United States.<\/p>\n\n<p>The session, led by <a href=\"https:\/\/nhc.timtul.es\/click\/6fab11e7291268d1603868051ce7859c\/https%3A%2F%2Fwww.linkedin.com%2Fin%2Ftalytacarteano%2F\" target=\"_blank\" rel=\"noreferrer noopener\">Talyta Carteano<\/a>, Medical Device Director at Asphalion, covered the classification and certification of medical devices, the role of regulatory bodies such as the FDA and Notified Bodies, and the importance of early regulatory planning in product development.<\/p>\n\n<p>The regulation of medical devices is a key aspect of developing and commercialising innovative products. Talyta Carteano examined the differences between the regulatory systems in Europe and the US, noting that following the 2017 legislative changes, it is currently faster to bring products to the US market than to the European one \u2014 although the current situation in the US brings some uncertainty regarding the new timelines and costs associated with the FDA. <\/p>\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-28f84493 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<figure class=\"wp-block-image size-large\"><img fetchpriority=\"high\" decoding=\"async\" width=\"810\" height=\"1080\" src=\"https:\/\/navarrahealthcluster.com\/wp-content\/uploads\/IMG_0802-1-810x1080.jpg\" alt=\"\" class=\"wp-image-10538\" style=\"aspect-ratio:1;object-fit:cover\" srcset=\"https:\/\/navarrahealthcluster.com\/wp-content\/uploads\/IMG_0802-1-810x1080.jpg 810w, https:\/\/navarrahealthcluster.com\/wp-content\/uploads\/IMG_0802-1-450x600.jpg 450w, https:\/\/navarrahealthcluster.com\/wp-content\/uploads\/IMG_0802-1-768x1024.jpg 768w, https:\/\/navarrahealthcluster.com\/wp-content\/uploads\/IMG_0802-1-1152x1536.jpg 1152w, https:\/\/navarrahealthcluster.com\/wp-content\/uploads\/IMG_0802-1-1536x2048.jpg 1536w, https:\/\/navarrahealthcluster.com\/wp-content\/uploads\/IMG_0802-1-scaled.jpg 1920w\" sizes=\"(max-width: 810px) 100vw, 810px\" \/><\/figure>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" width=\"810\" height=\"1080\" src=\"https:\/\/navarrahealthcluster.com\/wp-content\/uploads\/IMG_0820-810x1080.jpg\" alt=\"\" class=\"wp-image-10541\" style=\"aspect-ratio:1;object-fit:cover\" srcset=\"https:\/\/navarrahealthcluster.com\/wp-content\/uploads\/IMG_0820-810x1080.jpg 810w, https:\/\/navarrahealthcluster.com\/wp-content\/uploads\/IMG_0820-450x600.jpg 450w, https:\/\/navarrahealthcluster.com\/wp-content\/uploads\/IMG_0820-768x1024.jpg 768w, https:\/\/navarrahealthcluster.com\/wp-content\/uploads\/IMG_0820-1152x1536.jpg 1152w, https:\/\/navarrahealthcluster.com\/wp-content\/uploads\/IMG_0820-1536x2048.jpg 1536w, https:\/\/navarrahealthcluster.com\/wp-content\/uploads\/IMG_0820-scaled.jpg 1920w\" sizes=\"(max-width: 810px) 100vw, 810px\" \/><\/figure>\n<\/div>\n<\/div>\n\n<p>Key topics addressed included risk-based classification of medical devices, the roles of Notified Bodies in Europe and the FDA in the US, and the challenges companies face when certifying innovative products. The importance of considering regulation from the outset of product development, planning certification in advance, and having robust clinical evidence was also strongly emphasised to ensure success in the market. <\/p>\n\n<p>The certification process can be lengthy and costly, particularly in Europe, where the limited availability of Notified Bodies remains a challenge. In contrast, the FDA offers more transparency and approval routes such as 510(k), De Novo, or PMA, which may facilitate product approval \u2014 though each comes with its own risks. <\/p>\n\n<p><strong>In short, a well-defined regulatory strategy is essential for medical device companies to innovate and thrive in an increasingly demanding environment.<\/strong><\/p>\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Navarra Health Cluster and its member entity Asphalion launched a new training cycle titled &#8220;Regulatory Challenges in Pharmaceutical and Healthcare Innovation&#8221; on Tuesday 1 April, with a first session focused on the regulatory hurdles involved in innovation for medical devices, covering procedures in both Europe and the United States. The session, led by Talyta Carteano, [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":10537,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[57],"tags":[],"class_list":["post-10545","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Our new training series on regulatory challenges in pharmaceutical and healthcare innovation kicks off &#8226; Navarra Health Cluster<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/navarrahealthcluster.com\/en\/arranca-nuestro-nuevo-ciclo-formativo-sobre-los-desafios-regulatorios-en-la-innovacion-farmaceutica-y-sanitaria\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Our new training series on regulatory challenges in pharmaceutical and healthcare innovation kicks off &#8226; Navarra Health Cluster\" \/>\n<meta property=\"og:description\" content=\"Navarra Health Cluster and its member entity Asphalion launched a new training cycle titled &#8220;Regulatory Challenges in Pharmaceutical and Healthcare Innovation&#8221; on Tuesday 1 April, with a first session focused on the regulatory hurdles involved in innovation for medical devices, covering procedures in both Europe and the United States. The session, led by Talyta Carteano, [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/navarrahealthcluster.com\/en\/arranca-nuestro-nuevo-ciclo-formativo-sobre-los-desafios-regulatorios-en-la-innovacion-farmaceutica-y-sanitaria\/\" \/>\n<meta property=\"og:site_name\" content=\"Navarra Health Cluster\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-02T15:39:28+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-07T15:53:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/navarrahealthcluster.com\/wp-content\/uploads\/IMG_0808-1-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1920\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Jessica swiderski\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Jessica swiderski\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/navarrahealthcluster.com\/en\/arranca-nuestro-nuevo-ciclo-formativo-sobre-los-desafios-regulatorios-en-la-innovacion-farmaceutica-y-sanitaria\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/navarrahealthcluster.com\/en\/arranca-nuestro-nuevo-ciclo-formativo-sobre-los-desafios-regulatorios-en-la-innovacion-farmaceutica-y-sanitaria\/\"},\"author\":{\"name\":\"Jessica swiderski\",\"@id\":\"https:\/\/navarrahealthcluster.com\/#\/schema\/person\/b61800fe352bcd46894619c084a53d05\"},\"headline\":\"Our new training series on regulatory challenges in pharmaceutical and healthcare innovation kicks off\",\"datePublished\":\"2025-04-02T15:39:28+00:00\",\"dateModified\":\"2025-05-07T15:53:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/navarrahealthcluster.com\/en\/arranca-nuestro-nuevo-ciclo-formativo-sobre-los-desafios-regulatorios-en-la-innovacion-farmaceutica-y-sanitaria\/\"},\"wordCount\":306,\"publisher\":{\"@id\":\"https:\/\/navarrahealthcluster.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/navarrahealthcluster.com\/en\/arranca-nuestro-nuevo-ciclo-formativo-sobre-los-desafios-regulatorios-en-la-innovacion-farmaceutica-y-sanitaria\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/navarrahealthcluster.com\/wp-content\/uploads\/IMG_0808-1-scaled.jpg\",\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/navarrahealthcluster.com\/en\/arranca-nuestro-nuevo-ciclo-formativo-sobre-los-desafios-regulatorios-en-la-innovacion-farmaceutica-y-sanitaria\/\",\"url\":\"https:\/\/navarrahealthcluster.com\/en\/arranca-nuestro-nuevo-ciclo-formativo-sobre-los-desafios-regulatorios-en-la-innovacion-farmaceutica-y-sanitaria\/\",\"name\":\"Our new training series on regulatory challenges in pharmaceutical and healthcare innovation kicks off &#8226; Navarra Health Cluster\",\"isPartOf\":{\"@id\":\"https:\/\/navarrahealthcluster.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/navarrahealthcluster.com\/en\/arranca-nuestro-nuevo-ciclo-formativo-sobre-los-desafios-regulatorios-en-la-innovacion-farmaceutica-y-sanitaria\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/navarrahealthcluster.com\/en\/arranca-nuestro-nuevo-ciclo-formativo-sobre-los-desafios-regulatorios-en-la-innovacion-farmaceutica-y-sanitaria\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/navarrahealthcluster.com\/wp-content\/uploads\/IMG_0808-1-scaled.jpg\",\"datePublished\":\"2025-04-02T15:39:28+00:00\",\"dateModified\":\"2025-05-07T15:53:31+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/navarrahealthcluster.com\/en\/arranca-nuestro-nuevo-ciclo-formativo-sobre-los-desafios-regulatorios-en-la-innovacion-farmaceutica-y-sanitaria\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/navarrahealthcluster.com\/en\/arranca-nuestro-nuevo-ciclo-formativo-sobre-los-desafios-regulatorios-en-la-innovacion-farmaceutica-y-sanitaria\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/navarrahealthcluster.com\/en\/arranca-nuestro-nuevo-ciclo-formativo-sobre-los-desafios-regulatorios-en-la-innovacion-farmaceutica-y-sanitaria\/#primaryimage\",\"url\":\"https:\/\/navarrahealthcluster.com\/wp-content\/uploads\/IMG_0808-1-scaled.jpg\",\"contentUrl\":\"https:\/\/navarrahealthcluster.com\/wp-content\/uploads\/IMG_0808-1-scaled.jpg\",\"width\":2560,\"height\":1920,\"caption\":\"regulaci\u00f3n de dispositivos m\u00e9dicos\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/navarrahealthcluster.com\/en\/arranca-nuestro-nuevo-ciclo-formativo-sobre-los-desafios-regulatorios-en-la-innovacion-farmaceutica-y-sanitaria\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inicio\",\"item\":\"https:\/\/navarrahealthcluster.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Actualidad\",\"item\":\"https:\/\/navarrahealthcluster.com\/category\/actualidad\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Our new training series on regulatory challenges in pharmaceutical and healthcare innovation kicks off\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/navarrahealthcluster.com\/#website\",\"url\":\"https:\/\/navarrahealthcluster.com\/\",\"name\":\"Navarra Health Cluster\",\"description\":\"La mayor alianza en salud y biociencias de Navarra\",\"publisher\":{\"@id\":\"https:\/\/navarrahealthcluster.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/navarrahealthcluster.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/navarrahealthcluster.com\/#organization\",\"name\":\"Navarra Health Cluster\",\"url\":\"https:\/\/navarrahealthcluster.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/navarrahealthcluster.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/navarrahealthcluster.com\/wp-content\/uploads\/logo.png\",\"contentUrl\":\"https:\/\/navarrahealthcluster.com\/wp-content\/uploads\/logo.png\",\"width\":393,\"height\":116,\"caption\":\"Navarra Health Cluster\"},\"image\":{\"@id\":\"https:\/\/navarrahealthcluster.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.linkedin.com\/company\/navarrahealthcluster\/posts\/?feedView=all\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/navarrahealthcluster.com\/#\/schema\/person\/b61800fe352bcd46894619c084a53d05\",\"name\":\"Jessica swiderski\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/navarrahealthcluster.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/f6e6b4597cd0a87a101fb2ece2ea1ccc60a5271e09b541f3276d8e82e311a9e4?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/f6e6b4597cd0a87a101fb2ece2ea1ccc60a5271e09b541f3276d8e82e311a9e4?s=96&d=mm&r=g\",\"caption\":\"Jessica swiderski\"},\"url\":\"https:\/\/navarrahealthcluster.com\/en\/author\/navarra-capital\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Our new training series on regulatory challenges in pharmaceutical and healthcare innovation kicks off &#8226; Navarra Health Cluster","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/navarrahealthcluster.com\/en\/arranca-nuestro-nuevo-ciclo-formativo-sobre-los-desafios-regulatorios-en-la-innovacion-farmaceutica-y-sanitaria\/","og_locale":"en_US","og_type":"article","og_title":"Our new training series on regulatory challenges in pharmaceutical and healthcare innovation kicks off &#8226; Navarra Health Cluster","og_description":"Navarra Health Cluster and its member entity Asphalion launched a new training cycle titled &#8220;Regulatory Challenges in Pharmaceutical and Healthcare Innovation&#8221; on Tuesday 1 April, with a first session focused on the regulatory hurdles involved in innovation for medical devices, covering procedures in both Europe and the United States. The session, led by Talyta Carteano, [&hellip;]","og_url":"https:\/\/navarrahealthcluster.com\/en\/arranca-nuestro-nuevo-ciclo-formativo-sobre-los-desafios-regulatorios-en-la-innovacion-farmaceutica-y-sanitaria\/","og_site_name":"Navarra Health Cluster","article_published_time":"2025-04-02T15:39:28+00:00","article_modified_time":"2025-05-07T15:53:31+00:00","og_image":[{"width":2560,"height":1920,"url":"https:\/\/navarrahealthcluster.com\/wp-content\/uploads\/IMG_0808-1-scaled.jpg","type":"image\/jpeg"}],"author":"Jessica swiderski","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Jessica swiderski","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/navarrahealthcluster.com\/en\/arranca-nuestro-nuevo-ciclo-formativo-sobre-los-desafios-regulatorios-en-la-innovacion-farmaceutica-y-sanitaria\/#article","isPartOf":{"@id":"https:\/\/navarrahealthcluster.com\/en\/arranca-nuestro-nuevo-ciclo-formativo-sobre-los-desafios-regulatorios-en-la-innovacion-farmaceutica-y-sanitaria\/"},"author":{"name":"Jessica swiderski","@id":"https:\/\/navarrahealthcluster.com\/#\/schema\/person\/b61800fe352bcd46894619c084a53d05"},"headline":"Our new training series on regulatory challenges in pharmaceutical and healthcare innovation kicks off","datePublished":"2025-04-02T15:39:28+00:00","dateModified":"2025-05-07T15:53:31+00:00","mainEntityOfPage":{"@id":"https:\/\/navarrahealthcluster.com\/en\/arranca-nuestro-nuevo-ciclo-formativo-sobre-los-desafios-regulatorios-en-la-innovacion-farmaceutica-y-sanitaria\/"},"wordCount":306,"publisher":{"@id":"https:\/\/navarrahealthcluster.com\/#organization"},"image":{"@id":"https:\/\/navarrahealthcluster.com\/en\/arranca-nuestro-nuevo-ciclo-formativo-sobre-los-desafios-regulatorios-en-la-innovacion-farmaceutica-y-sanitaria\/#primaryimage"},"thumbnailUrl":"https:\/\/navarrahealthcluster.com\/wp-content\/uploads\/IMG_0808-1-scaled.jpg","articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/navarrahealthcluster.com\/en\/arranca-nuestro-nuevo-ciclo-formativo-sobre-los-desafios-regulatorios-en-la-innovacion-farmaceutica-y-sanitaria\/","url":"https:\/\/navarrahealthcluster.com\/en\/arranca-nuestro-nuevo-ciclo-formativo-sobre-los-desafios-regulatorios-en-la-innovacion-farmaceutica-y-sanitaria\/","name":"Our new training series on regulatory challenges in pharmaceutical and healthcare innovation kicks off &#8226; Navarra Health Cluster","isPartOf":{"@id":"https:\/\/navarrahealthcluster.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/navarrahealthcluster.com\/en\/arranca-nuestro-nuevo-ciclo-formativo-sobre-los-desafios-regulatorios-en-la-innovacion-farmaceutica-y-sanitaria\/#primaryimage"},"image":{"@id":"https:\/\/navarrahealthcluster.com\/en\/arranca-nuestro-nuevo-ciclo-formativo-sobre-los-desafios-regulatorios-en-la-innovacion-farmaceutica-y-sanitaria\/#primaryimage"},"thumbnailUrl":"https:\/\/navarrahealthcluster.com\/wp-content\/uploads\/IMG_0808-1-scaled.jpg","datePublished":"2025-04-02T15:39:28+00:00","dateModified":"2025-05-07T15:53:31+00:00","breadcrumb":{"@id":"https:\/\/navarrahealthcluster.com\/en\/arranca-nuestro-nuevo-ciclo-formativo-sobre-los-desafios-regulatorios-en-la-innovacion-farmaceutica-y-sanitaria\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/navarrahealthcluster.com\/en\/arranca-nuestro-nuevo-ciclo-formativo-sobre-los-desafios-regulatorios-en-la-innovacion-farmaceutica-y-sanitaria\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/navarrahealthcluster.com\/en\/arranca-nuestro-nuevo-ciclo-formativo-sobre-los-desafios-regulatorios-en-la-innovacion-farmaceutica-y-sanitaria\/#primaryimage","url":"https:\/\/navarrahealthcluster.com\/wp-content\/uploads\/IMG_0808-1-scaled.jpg","contentUrl":"https:\/\/navarrahealthcluster.com\/wp-content\/uploads\/IMG_0808-1-scaled.jpg","width":2560,"height":1920,"caption":"regulaci\u00f3n de dispositivos m\u00e9dicos"},{"@type":"BreadcrumbList","@id":"https:\/\/navarrahealthcluster.com\/en\/arranca-nuestro-nuevo-ciclo-formativo-sobre-los-desafios-regulatorios-en-la-innovacion-farmaceutica-y-sanitaria\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inicio","item":"https:\/\/navarrahealthcluster.com\/"},{"@type":"ListItem","position":2,"name":"Actualidad","item":"https:\/\/navarrahealthcluster.com\/category\/actualidad\/"},{"@type":"ListItem","position":3,"name":"Our new training series on regulatory challenges in pharmaceutical and healthcare innovation kicks off"}]},{"@type":"WebSite","@id":"https:\/\/navarrahealthcluster.com\/#website","url":"https:\/\/navarrahealthcluster.com\/","name":"Navarra Health Cluster","description":"La mayor alianza en salud y biociencias de Navarra","publisher":{"@id":"https:\/\/navarrahealthcluster.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/navarrahealthcluster.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/navarrahealthcluster.com\/#organization","name":"Navarra Health Cluster","url":"https:\/\/navarrahealthcluster.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/navarrahealthcluster.com\/#\/schema\/logo\/image\/","url":"https:\/\/navarrahealthcluster.com\/wp-content\/uploads\/logo.png","contentUrl":"https:\/\/navarrahealthcluster.com\/wp-content\/uploads\/logo.png","width":393,"height":116,"caption":"Navarra Health Cluster"},"image":{"@id":"https:\/\/navarrahealthcluster.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/navarrahealthcluster\/posts\/?feedView=all"]},{"@type":"Person","@id":"https:\/\/navarrahealthcluster.com\/#\/schema\/person\/b61800fe352bcd46894619c084a53d05","name":"Jessica swiderski","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/navarrahealthcluster.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/f6e6b4597cd0a87a101fb2ece2ea1ccc60a5271e09b541f3276d8e82e311a9e4?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f6e6b4597cd0a87a101fb2ece2ea1ccc60a5271e09b541f3276d8e82e311a9e4?s=96&d=mm&r=g","caption":"Jessica swiderski"},"url":"https:\/\/navarrahealthcluster.com\/en\/author\/navarra-capital\/"}]}},"_links":{"self":[{"href":"https:\/\/navarrahealthcluster.com\/en\/wp-json\/wp\/v2\/posts\/10545","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/navarrahealthcluster.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/navarrahealthcluster.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/navarrahealthcluster.com\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/navarrahealthcluster.com\/en\/wp-json\/wp\/v2\/comments?post=10545"}],"version-history":[{"count":2,"href":"https:\/\/navarrahealthcluster.com\/en\/wp-json\/wp\/v2\/posts\/10545\/revisions"}],"predecessor-version":[{"id":10547,"href":"https:\/\/navarrahealthcluster.com\/en\/wp-json\/wp\/v2\/posts\/10545\/revisions\/10547"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/navarrahealthcluster.com\/en\/wp-json\/wp\/v2\/media\/10537"}],"wp:attachment":[{"href":"https:\/\/navarrahealthcluster.com\/en\/wp-json\/wp\/v2\/media?parent=10545"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/navarrahealthcluster.com\/en\/wp-json\/wp\/v2\/categories?post=10545"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/navarrahealthcluster.com\/en\/wp-json\/wp\/v2\/tags?post=10545"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}